As part of our ongoing AI series, we had the opportunity to delve into the groundbreaking work of Axolotl Biosciences, a trailblazer in the realm of human tissue engineering. Spearheaded by Dr. Stephanie Willerth, the company has been at the forefront of integrating artificial intelligence into the creation of 3D-printed human tissue models. Having showcased their innovative approach at InvestMidwest in 2023, Axolotl has continued to make significant strides in its field.
Axolotl Biosciences specializes in developing advanced reagents for 3D printing, which is pivotal for creating accurate human tissue models. This ambitious endeavor aims to revolutionize how we understand and manipulate biological tissues, offering immense potential for medical research and therapeutic applications. Dr. Willerth shared insights into how the company has embraced machine learning to optimize their processes. "Using AI and machine learning, we can analyze extensive datasets to predict which cells will survive and provide the best chance of producing viable tissue models," she explained.
The integration of AI has proven transformative for Axolotl. Traditionally, the development of tissue models involved laborious experimentation and significant trial-and-error. However, by incorporating AI, Axolotl has streamlined its experimental design process, dramatically reducing the number of required experiments. This shift has not only minimized costs but also enhanced the precision of their outcomes. "AI allows us to generate optimal formulations, which translates to significant time and cost savings," Dr. Willerth noted. "The more we use AI, the more impressed I am with its accuracy and efficiency."
Initially, there was some skepticism surrounding the application of AI in this niche field. Dr. Willerth acknowledged this sentiment but highlighted how practical benefits soon became apparent. "Normally, we would need to evaluate a multitude of parameters and concentrations for our components. AI has enabled us to optimize these experiments by finding the most effective formulas, which in turn saves money and resources," she elaborated. The ability of AI to predict and refine experimental outcomes has been invaluable, transforming how Axolotl approaches their research and development processes.
Despite the numerous advantages, the application of AI in sensitive areas like tissue engineering brings its own set of concerns. Privacy and data security are paramount, particularly given the sensitive nature of medical and biological data. Dr. Willerth emphasized the importance of handling this information with care. "We're dealing with intellectual property and highly sensitive data. It's crucial to establish robust parameters and guidelines for how this data is collected and used," she advised.
As Axolotl Biosciences continues to push the boundaries of what AI can achieve in tissue engineering, the company remains acutely aware of the broader ethical and practical implications. Their journey mirrors the larger narrative of AI in healthcare: a tool of immense potential that must be wielded responsibly. The promise of AI to revolutionize fields like human tissue modeling is matched by the need for careful consideration of its applications and impacts.
Axolotl’s commitment to leveraging AI for innovation, while navigating the associated challenges, underscores a broader trend in healthcare. As the company advances its technology, it paves the way for new possibilities in medical research and treatment, embodying the transformative power of AI in enhancing human health and well-being.
If you’d like to participate in our AI blog please reach out to Lyndsey Gruber.